Patents by Inventor Annika Hagendorf

Annika Hagendorf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION COMPRISING A GLP-1 AGONIST, AN INSULIN AND METHIONINE
    Publication number: 20220133890
    Abstract: A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof, an insulin or/and a pharmacologically tolerable salt thereof, and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin where appropriate.
    Type: Application
    Filed: July 2, 2021
    Publication date: May 5, 2022
    Inventors: Annika Hagendorf, Gerrit Hauck, Werner Mueller, Isabell Schoettle, Verena Siefke-Henzler, Katrin Tertsch
  • Stable IGG4 Based Binding Agent Formulations
    Publication number: 20200222534
    Abstract: The present invention provides stable pharmaceutical antibody formulations, including liquid drug product formulations and lyophilized drug product formulations, comprising an IgG4 binding agent and a citrate buffer, wherein the pH of the formulation is at or below both pH 6 and the pI of the binding agent. The formulations can be used in the treatment of chronic bowel diseases or rheumatoid arthritis.
    Type: Application
    Filed: December 9, 2019
    Publication date: July 16, 2020
    Inventors: Julia Schnieders, Dirk Usener, Sabrina Ruggeberg, Ahmed Youssef, Martina Kirsch, Annika Hagendorf
  • PHARMACEUTICAL COMPOSITION COMPRISING A GLP-1 AGONIST, AN INSULIN AND METHIONINE
    Publication number: 20200188516
    Abstract: A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof, an insulin or/and a pharmacologically tolerable salt thereof, and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin where appropriate.
    Type: Application
    Filed: October 28, 2019
    Publication date: June 18, 2020
    Inventors: Annika Hagendorf, Gerrit Hauck, Werner Mueller, Isabell Schoettle, Verena Siefke-Henzler, Katrin Tertsch
  • Stable IGG4 based binding agent formulations
    Patent number: 10525130
    Abstract: The present invention provides stable pharmaceutical antibody formulations, including liquid drug product formulations and lyophilized drug product formulations, comprising an IgG4 binding agent and a citrate buffer, wherein the pH of the formulation is at or below both pH 6 and the pI of the binding agent. The formulations can be used in the treatment of chronic bowel diseases or rheumatoid arthritis.
    Type: Grant
    Filed: January 26, 2017
    Date of Patent: January 7, 2020
    Assignee: Sanofi
    Inventors: Julia Schnieders, Dirk Usener, Sabrina Ruggeberg, Ahmed Youssef, Martina Kirsch, Annika Hagendorf
  • Pharmaceutical composition comprising a GLP-1 agonist, an insulin and methionine
    Patent number: 10029011
    Abstract: A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof, an insulin or/and a pharmacologically tolerable salt thereof, and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin where appropriate.
    Type: Grant
    Filed: November 11, 2010
    Date of Patent: July 24, 2018
    Assignee: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Annika Hagendorf, Gerrit Hauck, Werner Mueller, Isabell Schoettle, Verena Siefke-Henzler, Katrin Tertsch
  • Pharmaceutical Composition Comprising a GLP-1 Agonist, an Insulin and Methionine
    Publication number: 20180200370
    Abstract: A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof, an insulin or/and a pharmacologically tolerable salt thereof, and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin where appropriate.
    Type: Application
    Filed: November 3, 2017
    Publication date: July 19, 2018
    Inventors: Annika Hagendorf, Gerrit Hauck, Werner Mueller, Isabell Schoettle, Verena Siefke-Henzler, Katrin Tertsch
  • STABLE IGG4 BASED BINDING AGENT FORMULATIONS
    Publication number: 20170232104
    Abstract: The present invention provides stable pharmaceutical antibody formulations, including liquid drug product formulations and lyophilized drug product formulations, comprising an IgG4 binding agent and a citrate buffer, wherein the pH of the formulation is at or below both pH 6 and the pI of the binding agent. The formulations can be used in the treatment of chronic bowel diseases or rheumatoid arthritis.
    Type: Application
    Filed: January 26, 2017
    Publication date: August 17, 2017
    Inventors: Julia Schnieders, Dirk Usener, Sabrina Ruggeberg, Ahmed Youssef, Martina Kirsch, Annika Hagendorf
  • Stable IgG4 based binding agent formulations
    Patent number: 9592289
    Abstract: The present invention provides stable pharmaceutical antibody formulations, including liquid drug product formulations and lyophilized drug product formulations, comprising an IgG4 binding agent and a citrate buffer, wherein the pH of the formulation is at or below both pH 6 and the pI of the binding agent. The formulations can be used in the treatment of chronic bowel diseases or rheumatoid arthritis.
    Type: Grant
    Filed: March 26, 2013
    Date of Patent: March 14, 2017
    Assignee: SANOFI
    Inventors: Julia Schnieders, Dirk Usener, Sabrina Ruggeberg, Ahmed Youssef, Martina Kirsch, Annika Hagendorf
  • PHARMACEUTICAL COMPOSITION COMPRISING A GLP-1 AGONIST, AN INSULIN AND METHIONINE
    Publication number: 20120295846
    Abstract: A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof, an insulin or/and a pharmacologically tolerable salt thereof, and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin where appropriate.
    Type: Application
    Filed: November 11, 2010
    Publication date: November 22, 2012
    Applicant: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Annika Hagendorf, Gerrit Hauck, Werner Mueller, Isabell Schoettle, Verena Siefke-Henzler, Katrin Tertsch
  • INSULIN PREPARATIONS CONTAINING METHIONINE
    Publication number: 20120252724
    Abstract: The invention relates to an aqueous pharmaceutical formulation having insulin, an insulin analog, or an insulin derivative, and methionine; and to the production thereof, to the use thereof for treating diabetes mellitus, and to a medication for treating diabetes mellitus.
    Type: Application
    Filed: July 2, 2010
    Publication date: October 4, 2012
    Applicant: SANOFI-AVENTIS
    Inventors: Isabell Schoettle, Annika Hagendorf, Christiane Fuerst, Gerrit Hauck, Verena Siefke-Henzler, Walter Kamm, Julia Schnieders